Immuneering Corp. (IMRX)
4.995
-0.26
(-4.86%)
USD |
NASDAQ |
Feb 20, 16:00
5.02
+0.02
(+0.50%)
After-Hours: 20:00
Immuneering Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -246.8% |
| Verastem, Inc. | -876.3% |
| Phathom Pharmaceuticals, Inc. | -60.55% |
| Tango Therapeutics, Inc. | 29.52% |
| Moderna, Inc. | -121.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -78.54% |
| Return on Assets | -68.97% |
| Return on Invested Capital | -74.71% |
| Return on Net Operating Assets | -535.9% |